Compounded Semaglutide Research Guide

Full name: Compounded Semaglutide (503B Pharmacy)

Compounded semaglutide from 503B pharmacies became the most prescribed telemedicine weight loss medication. Provides the same GLP-1 receptor agonism as brand-name Ozempic/Wegovy at lower cost through compounding pharmacies.

How Compounded Semaglutide Works

Identical to branded semaglutide - a GLP-1 receptor agonist with a fatty acid chain for albumin binding, providing extended half-life. Reduces appetite, slows gastric emptying, and improves insulin sensitivity.

Dosing Protocol

• Typical dose: 0.25-2.4 mg
• Frequency: Once weekly
• Duration: 12-52+ weeks
• Route: Subcutaneous injection

Reported Benefits

• Significant weight loss (15-20%)
• Appetite suppression
• Improved glycemic control
• Cardiovascular benefits
• Reduced food noise

Potential Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Injection site reactions
• Potential pancreatitis (rare)

Research Citations

1. STEP trials semaglutide 2.4mg (2022) - Achieved mean 14.9% body weight loss at 68 weeks in non-diabetic adults with overweight/obesity.

Related Weight Management Compounds

• AOD-9604 - Full Profile
• Semaglutide - Full Profile
• Tirzepatide - Full Profile
• Retatrutide - Full Profile
• Tesofensine - Full Profile
• CagriSema - Full Profile

View full Compounded Semaglutide profile with 3D molecule viewer →